在阿尔茨海默病中微质代谢重编程:途径,机制和治疗影响
Feng-Ge Yang1, He Yang2, Sheng-Wang Han2
1Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Ageing research reviews
|February 6, 2026
概括
微质 (MG) 代谢显著影响阿尔茨海默病 (AD) 的进展. 了解微质代谢重编程为早期AD诊断和向治疗提供了新的途径.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 代谢过程中的代谢.
背景情况:
- 微质细胞 (MG) 是中枢神经系统中的主要免疫细胞.
- 微质代谢越来越多地被认为是它在神经退行性疾病 (如阿尔茨海默氏症) 中的作用.
- 微质中的代谢重编程会影响AD的发病和进展.
研究的目的:
- 在阿尔茨海默病中全面审查微质代谢重编程.
- 探索关键能量基质 (葡萄糖,脂肪酸,氨基酸) 和微质代谢中的信号通路的作用.
- 讨论代谢学在早期阿尔茨海默氏症诊断和针对微质功能的新型治疗策略中的潜力.
主要方法:
- 文献综述专注于阿尔茨海默病中的微质代谢.
- 对调节微质代谢重编程的信号通路的分析 (例如TREM2,PI3K-AKT-mTOR,HIF-1α,AMPK,PPAR,LXR).
- 对AD的代谢学应用和治疗目标的探索.
主要成果:
- 微质细胞的代谢重编程,涉及葡萄糖,脂肪酸和氨基酸通路,是AD病原体的核心.
- 特定的分子信号通路关键地调节了微质中的这些代谢转变.
- 代谢学对早期AD检测有希望,针对微质代谢的治疗干预可以减轻疾病的进展.
结论:
- 微质新陈代谢重编程与阿尔茨海默氏病级联密切相关.
- 准微质新陈代谢是开发新型AD治疗方法的有希望的战略.
- 对微质代谢重编程的动态网络的进一步研究可以为神经保护的创新药物开发提供信息.
相关概念视频
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...